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Introduction
Mabruka, an 18 year old from Ethiopia has experienced living through tuberculosis (TB). TB
is a communicable disease often perceived as a disease of the past in high-income countries, like
the US; however, TB afflicts the lives of people worldwide daily. Mabruka, who was initially
from Ethiopia, knew of TB but assumed that she “didn’t think” she “could get TB” while living
in the US. Mabruka was sick for months with symptoms growing increasingly worse. After
several visits to the doctor, she was repeatedly prescribed cough medicine but as the months
went by, her cough became increasingly severe, she had unexplained weight loss chest pain,
difficulty breathing and she began to cough up blood. A visit to the emergency room, months
after her initial symptoms, led to her being diagnosed with TB.1 Mabruka is one of thousands of
people, who experience active TB in the US every year, and who suffer from the stigma
surrounding TB in the US.2
Despite TB being preventable and treatable, the World Health Organization (WHO) reported
that in 2018, an estimated 10.0 million people fell ill with TB globally.3 TB is the most fatal
infectious disease with an estimated 1.2 million deaths among people who are HIV-negative and
an estimated 251,000 deaths among people, who are HIV-positive in 2018.4 TB is highly
infectious and can infect anyone; however, the burden of TB is highest in low-and-middle
income countries (LMICs) and among marginalized communities. The highest risk groups for
TB, according to the Global Fund, are indigenous populations, imprisoned populations,

1“Mabruka’s

Story,” TB Personal Stories, CDC, last reviewed March 7, 2013.
https://www.cdc.gov/tb/topic/basics/mabrukastory.htm
2 For more TB personal testimonies refer to CDC TB Personal Stories
https://www.cdc.gov/tb/topic/basics/personalstories.htm or we are TB https://www.wearetb.com/resume
3 World Health Organization (WHO). Global Tuberculosis Report 2019. Geneva: World Health Organization,
2019, 1.
4 WHO. Global Tuberculosis Report 2019, 1.
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individuals with HIV, and migrants and refugees.5 While TB can be treated, every year, 4.1
million cases go undetected and untreated which continues to exacerbate the TB burden
globally.6 TB is a disease with global reach but it does disproportionately impact LMICs;
however, TB is not eradicated in higher-income countries such as the US.
In the US, 9,025 TB cases were reported to the Center for Disease Control (CDC), the
leading public health institute in the US. 7 The CDC sets the standard for public health practice
throughout the US and is a major actor in advocacy surrounding diseases, such as TB. The
website for CDC is full of info graphs, informative reports, and of personal testimonies of people
who have survived TB like Mabruka. The CDC collects data from health departments nationwide
to present an overall picture of the burden of TB. In the CDC’s presentation of TB, they present
what the number of TB cases, the mortality rate, the risk factors, where the TB cases were, and
then who is infected. One of the key variables for individuals of TB, as presented by the CDC, is
whether the cases are of individuals who are “foreign-born” or US-born. The CDC notes that the
70.2% of the cases in the United States are among “foreign-born” individuals. 8 The binary
classification of “foreign-born” and US-born is highly problematic for a number of reasons but
the first being that the average number of years that the individuals had lived in the US, at the
time of diagnosis, was at least 10 years. So the need to classify whether a person with TB was
born in the US or not suggests that the CDC considers the country-of-origin to be the main risk
factor in the development of active TB infection rather than the social- contextual factors that are

“Key Populations: TB,” Key Populations, The Global Fund, Published September 13,
2019. https://www.theglobalfund.org/en/key-populations/
6 Médecins sans Frontières (MSF). Burden Sharing or Burden Shifting? How the HIV/TB Response is Being
Derailed. Geneva: MSF, October 2019, 5.
7“TB: Data and Statistics,” Tuberculosis (TB), CDC, last reviewed September 9, 2019,
https://www.cdc.gov/tb/statistics/default.htm
8 “Trends in Tuberculosis, 2018,” CDC, last reviewed October 29 2019,
https://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm
5
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in play in the US. An example of such a factor is food insecurity. According to the WHO,
undernourishment is the most significant risk in the development of active TB. Food insecurity is
a broader term that encompasses undernourishment and also other factors detailing the
accessibility of all people to nutritious food. Food insecurity could be a highly significant factor
in developing TB in the US. However, the CDC does not recognize either food insecurity or
undernourishment as a main factor in the development of active TB in the US. The focus is on
the birthplace of the people with TB. This association perpetuates racist and xenophobic
sentiments that immigrant bring TB from elsewhere. The focus on birthplace of people with TB
echoes a racist history in the US of blaming immigrants and other minorities as the causes and/or
carrier of TB disease. Rather, the focus should be on other contributing risk factors that consider
the structural context of each individual with TB.
The implications of focusing on the birthplace of an individual with TB, which means that
the social-determinants are ignored, impacts more than just awareness of the TB burden but also
factors into what aspects of TB are funded both domestically and globally. The US has been the
largest donor for global TB initiatives; however, the interest in foreign aid is dwindling. The
guiding ideology for US TB funding , both domestically and abroad, is neoliberalism. The lack
of programming that focuses on structural issues, such as food insecurity, can be attributed to
neoliberal attitudes. The goal of neoliberalism is to have a free market and to invest in efforts
that make a profit. So, most of US TB initiatives both globally and domestically, advocate
heavily for the development of vaccines and drugs and ignore broader structural issues, such as
food insecurity, which are less likely to make immediate profit.
The CDC’s emphasis on whether a TB case in the US is “foreign-born” or US-born” person,
suggests the neoliberal influence domestically because this birthplace is the considered the most
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important variable rather than the structural contexts within the US itself that contribute to the
activation of TB. This characterization is flawed and perpetuates an anti-immigrant idea of
immigrants as carriers of disease. It speaks to a larger issue of the importance of the presentation
of data within public health, specifically for TB. The characterization of TB disease as being one
that most heavily impacts “foreign-born” people impacts funding, the perception of the burden,
and the response to the burden of TB. Focusing on the TB patient’s country-of-origin may lead
to less effective interventions both domestically and abroad, as well as hinder the efforts to
eradicate TB because it relies on the assumption that TB disease is from elsewhere and ignores
the structural risk factors that contribute to the activation of TB in the US.

The Burden of Tuberculosis in the United States: A Disease from Elsewhere?
While compared to other countries the US has a low rate of active TB cases, thousands
each year still suffer from active TB. In 2018, 9,025 cases or 2.8 cases per 100,000 people, of
active TB were reported in the United States.9 While TB can impact anyone, according to the
CDC, marginalized communities such as ethnic and racial minorities, as well as individuals not
born in the US, are disproportionately impacted by TB in the US. In 2019, the CDC reported,
that immigrants, or “foreign-born” individuals, totaled 70.2% of the cases in the United States. 10
Similar to the national data, state-level and city-level reports from California and New
York City, respectively, presented the data in a similar fashion and emphasized that the majority
of TB cases were among “foreign-born” individuals. California and New York City are pertinent

9“TB:

Data and Statistics,” Tuberculosis (TB), CDC, last reviewed September 9, 2019,
https://www.cdc.gov/tb/statistics/default.htm
10 “Trends in Tuberculosis, 2018,” CDC, last reviewed October 29 2019,
https://www.cdc.gov/tb/publications/factsheets/statistics/tbtrends.htm
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locations because across history these locations have some of the highest burdens of TB in the
US. The focus on the case rate among “foreign-born” individuals is common in both the New
York Health Department TB Report for 2018 as well as the California Health Department TB
Report for 2018.11 There are several issues with categorizing “foreign born” as more at-risk of
contracting TB. First, there is demographic evidence indicating that many immigrants who
contract TB have resided in the US for more than a decade at the time of diagnosis. For example,
in the New York City Health Department reported that in 2018 TB, 84% of TB cases in New
York City were among “non-U.S.-born patients” and the median number of years that these
patients had been in the US was 13 years.12 Similarly, in the California Department of Public
Health reported that in 2018, 83% of TB cases in California were among “persons who were
born outside of the U.S” and half of these individuals were diagnosed with TB “20 years or
more after arrival in the U.S.”13 Despite that most patients in both NYC and in California had
resided in the US for over 10 years, the reports published by the health departments still
highlighted that the patient was not born in the US. This relates to how health departments as
well as the CDC collects data in that the country of birth is key to the presentation of the burden
of TB in the US. The insistence of the categorization foreign-birth or born in the US insinuates
that TB was imported from elsewhere, namely in a country with a high-burden of TB. However,
this claim relies too heavily on outdated information regarding the incubation period of TB.
Experts have long thought that the incubation period for TB was several years following
initial exposure to Mycobacterium tuberculosis; however, following the analysis of many

New York City Bureau of Tuberculosis Control. End TB NYC: NYC Bureau of Tuberculosis Control Annual
Summary, 2018.” Released March 2019, 4. https://www1.nyc.gov/assets/doh/downloads/pdf/tb/tb2018.pdf
Tuberculosis Control Branch, Report on Tuberculosis in California 2018, California Department of Public Health,
Richmond, CA. July 2019.
12 New York City Department of Health and Mental Hygiene, Bureau of Tuberculosis Control Annual Summary
2018. Queens, NY, 2019, 19,20
13 California Department of Public Health, Report on Tuberculosis in California, 2018.2.
11
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studies, Behr et al. argue that most TB cases occur within two years after initial infection.14 So, if
TB has higher case rates among “foreign-born” people, many of whom have resided in the US
for at least a decade, then either these individuals are infected with tuberculosis within the US, or
they have travelled to a “high-burden” country, or the latent TB infection activates years after
they arrive in the US which implies certain social-contextual factors of living in the US that
influence the activation of TB. All three of these scenarios have a commonality in that the
country-of-birth is not relevant. Therefore, the CDC and health departments are focusing on the
wrong variable i.e the place of birth rather than presenting data based on contextual factors of the
lives of immigrants in the US that may contribute to the activation of TB.

The Science of Mycobacterium tuberculosis
. TB is caused by Mycobacterium tuberculosis and is an airborne disease spread through
droplets of the bacteria via coughing or sneezing. However, most people who are infected with
M.tuberculosis do not have ‘active’ TB but rather latent TB infection, meaning they are not
contagious nor do they experience symptoms. M.tuberculosis infection and disease is a spectrum
which is demonstrated in figure 1. The spectrum ranges, as depicted in figure 1, from infection
that is eliminated by the immune system to latent tuberculosis infection, sub-clinical infection,
and then active TB infection. TB control and interventions focus on either ‘latent’ or ‘active’ TB
infection.

14Marcel

A Behr, Paul H Edelstein, and Lalita Ramakrishnan, “Revisiting the Timetable of Tuberculosis,” The BMJ
362, (Aug 2018), 1-2.
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Figure 1: The spectrum of tuberculosis infection and disease. 15 This image demonstrates
the spectrum between latent and active TB infection. Latent TB is not infectious and
asymptomatic; however, it could develop into active TB, which is infectious and
symptoms vary from ‘mild’ to ‘severe.’ On average, latent TB develops into active TB
within two years of infection.

Latent TB treatment is the primary method of TB prevention treatment and is one of the
CDC’s main strategies for TB control in the US. According to the WHO, latent TB infection is a
“state of persistent immune response to stimulation by Mycobacterium tuberculosis antigens
without evidence of clinically manifested active TB.”16 The WHO estimates that 1 billion people
have latent TB and the CDC reported that an estimated 13 million people in the U.S have latent

Jennifer Furin, Helen Cox, and Madhukar Pai. “Tuberculosis,” The Lancet 393, (March 2019), 1643.
Image from Madhukar Pai et al. “Tuberculosis,” Natural Review 2, (2016): 3.
16 WHO, Latent tuberculosis infection: Updated and consolidated guidelines for programmatic management.”
Released 2018, 1.
15
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infection.17 While these numbers are jarring, the WHO reports that on average, only 5-15% of
those infected with TB go on to develop active infection.18 Behr et al. concluded that the reported
burden of latent TB worldwide is ‘overestimated’ because “it reflects immunoreactivity to either
past or present infection” meaning that the individual is still immunoreactive to TB and will test
positive on a skin test, even a year after treatment. 19 The concept of ‘latency’ has also altered
with new evidence in recent years, which increasingly suggests that the burden of latent TB
worldwide and the incubation period of M. tuberculosis inside an individual body is vastly latent
overstated.
For decades, experts have thought the latency period could last for several years meaning
that once someone was infected with M.tuberculosis then it could activate and the disease would
manifest later in their lives. Recent analysis of multiple longitudinal epidemiological studies,
however, indicate that the incubation period for M.tuberculosis is on average two years,
maximum, and the vast majority of global active TB cases, is from “recently transmitted
infection.” 20 Behr et al.’s conclusions indicate that the characterization of “foreign-born” people
as being more at-risk of developing TB, without any acknowledgement of the social
determinants related to increased risk of TB , is nearsighted since on a national and local level
the average number of years that these patients had resided in the US was over 10 years at the
time of diagnosis.

“TB: Data and Statistics,” Tuberculosis (TB), CDC, last reviewed September 9, 2019,
https://www.cdc.gov/tb/statistics/default.htm
Tuberculosis: Overview,” World Health Organization, last modified 2020. https://www.who.int/health
topics/tuberculosis#tab=tab_1
18 WHO, “Tuberculosis: Overview.”
19 Behr, Edelstein, and Ramakrishnan, “Revisiting the Timetable of Tuberculosis,” 3.
20 Marcel A Behr, Paul H Edelstein, and Lalita Ramakrishnan, “Revisiting the Timetable of Tuberculosis,” The BMJ
362, (Aug 2018), 1-2.
17
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In a study conducted by the Division of Tuberculosis Elimination for the CDC, Courney
M. Yuen et al. analyzed the 26,586 cases of TB between 2011 and 2014 to research the
percentage of TB cases that were attributed to ‘limited’ recent transmission rather than
‘extensive’ recent transmission.21 They found that 14% of the cases were attributable to recent
transmission. 61% of the recent transmission cases were due to ‘limited’ recent transmission and
39% was attributed to ‘extensive’ recent transmission.22 Yuen et al., however, did not explain
their definitions for ‘recent’ or ‘extensive.’ 23 The lack of definitions highlights the importance of
data collection and presentation in accurately depicting the burden of disease. Also, the lack of
definitions make conclusions based on a person being infected elsewhere and then developing
TB in the US difficult. In this study, ‘foreign-birth’ was negatively associated with ‘extensive’
and ‘limited’ recent transmission.24 Cases attributable to ‘extensive’ recent transmission were
more likely in people who had arrived in the U.S. more than 10 years prior to the diagnosis of
TB rather than patients, who had arrived 1-5 years prior to their diagnosis.25 They found that
92.5% of TB cases among foreign-born individuals in this period were NOT attributed to recent
transmission.26 This study adds on to the CDC’s declaration that for TB cases among “foreignborn” populations, Yuen et al. indicates that TB was not recently transmitted in this population
and further insinuates that TB in this population, and thereby for most of the TB cases in the U.S.

Courtney M. Yuen et al., “Recent Transmission of Tuberculosis—United States, 2011-2014,” PLoS ONE 11, no. 4
(April 2018).doi:10.1371/journal.pone.0153728.
22 Yuen et al. “Recent Transmission of Tuberculosis—United States,” 3-4.
23 “Estimates of Recent Transmission,” 2017 State and City TB Report, the CDC, last reviewed February 1, 2019.
In order to better understand the findings of this paper, I assumed that the definition of ‘extensive’ recent.
transmission and ‘limited’ recent transmission was in alignment of the CDC State and City TB Report because this
paper was published by the CDC’s Division. The CDC states that a case is considered to be caused by ‘extensive’
recent transmission if the case “belongs to a plausible transmission chain of six or more cases with at least five
preceding cases in the chain within the previous three years.”23 Otherwise, the cases are considered to be caused by
‘limited’ recent transmission.
24 Yuen et al. “Recent Transmission of Tuberculosis—United States,” 3-4.
25 Yuen et al. “Recent Transmission of Tuberculosis—United States,” 5.
26 Yuen et al. “Recent Transmission of Tuberculosis—United States,” 7.
21
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is brought from their country of origin. It does not acknowledge the potential for becoming
infecting by travelling to a high-burden area or returning to their home country, if it is considered
a high-burden country.
Another study by O.R. McCarthy found that 1/5 of the Asian immigrants in a London
neighborhood, who developed tuberculosis in the five year period following their initial arrival,
had visited Asia during that period. Another 1/3 who had developed TB, he concluded became
infected in Asia, before leaving, and developed TB in the UK. The remaining half had acquired
TB while in the UK. 27 So around half of the TB cases were said to be due to infection in Asia
and the other half in the UK. The categorization of ‘foreign-born’ and Yuen et al. do not
acknowledge the possibilities of travelling to high-burden countries, which do not necessarily
have to be the country of origin. There is a need to better understand “foreign-born” communities
in the U.S and the social-determinants of health that influence the activation or the infection of
TB in the US.

The “At-Risk” Immigrant
The second issue with organizing TB cases as “foreign-born” or US-born inherently
shifts the blame to the country of origin or even, the individual themselves, rather than
acknowledging the social context where immigrants live that perhaps triggers or leads to TB
exposure. Blaming immigrants for disease is a human phenomenon with historical roots from the
plague in the 16th century, when in Milan they “blamed plague’s spread preemptively on
travelers or undesirable migrants.”28 There is a history in the United States of migrant

O.R. McCarthy. “Asian Immigrant Tuberculosis—The Effect of Visiting Asia,” British Journal of Diseases of the
Chest 78, no. 3 (1984): 248.
28 Anne Carmichael, “ Plague Persistence in Western Europe: A Hypothesis.” The Medieval Globe 1, no. 1 (2014):
167.
27
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populations being demonized as carriers of communicable diseases. Immigrants are often
conceptualized as “at-risk” which has “helped cement wider cultural stereotypes and fuel stigma
and racism.”29 In the US, TB has disproportionately impacted migrants mostly because of the
working conditions as well as economic and social inequality that marginalized immigrant
communities face in the US, than their origins.30 In the last century, migrants have been blamed
for diseased such as TB in the US for both xenophobic reasons but also raced-based theories of
disease. In the twenty-first century, highlighting the birthplace of people with TB in the US
perpetuates an anti-immigrant sentiment and xenophobic idea that immigrants, in particular
immigrants from low-and-middle-income countries (LMICs), are the cause and carriers of
disease.

Historical Context of Race-Based Theories of Disease
The categorization of migrants as an “at-risk” group in the USA is not a modern issue but
embedded in a historical context rooted in racism and xenophobia. Raced-based theories of
disease were pervasive in the late 19th century and at the turn of the 20th century largely due to
the rise of eugenics, even after Robert Koch’s discovery of the bacteria and germ theory. In the
1870s, Native Americans were dying of TB at an alarming rate and doctors attributed it to their
‘inferiority’ as a race. For example, in 1887, Dr. William Coe, wrote “the Indian is more
susceptible to this malady than the white man under like conditions.” 31 Coe’s language blatantly
portrays the racist undertones for Native American’s susceptibility to TB.

Heide Castañeda,“Im/Migration and Health: Conceptual, Methodological, and Theoretical Propositions for
Applied Anthropology.” NAPA Bulletin, 34 (November 2010), 16.
30 Castañeda, “Im/Migration and Health,” 17.
31Christian W. McMillen. Discovering Tuberculosis: A Global History, 1900 to the present. (New Haven: Yale
University Press, 2015), 19
29

14

Later at the turn of the 20th century, notions of racial superiority among white Americans
were omnipresent with ideas that physical strength and vigor were the reason for their social and
political supremacy.32 While it may seem that public health officials have evolved past this
thinking, the race and ethnicity categorization on the CDC’s publication on TB lies dangerously
close to racial-based reasoning for developing TB. For example, in an infographic (Figure 2)
and in their official publications, the CDC shows ‘Asians’ as the most impacted group in the US,
accounting for 35.3% of TB cases.33 However, there is not any clarification of what they mean
by ‘Asian.’ In order to hone in on who is most impacted by TB, it is important to specify whether
the CDC means people who have migrated from an Asian country to the US or people of Asian
descent. The same can be said for the “Hispanics or Latinos” figure which does not provide more
specificity on whether they mean exclusively the ethnicity or whether this includes immigrants,
as well. While it seems that the intention was to indicate that racial and ethnic minorities are
disproportionally impacted by TB because of other structural inequalities in the US, that is not
clear, and so it is disconcerting that the most prominent public health voice in the US, the CDC,
is perpetuating an antiquated racial-based reasoning for TB in their health communications. Most
importantly, many immigrants who are diagnosed with TB bear the brunt of both being
perceived as “foreign” even though most have lived in the US for more than a decade and they
are also racial/ethnic minorities. Both of these categories are stressed as important in the TB
burden of the US, according to the CDC; however, the conflation of “foreign-born” and
racial/ethnic minority could have implications of race-based reasoning for TB.

32
33

Emily Abel, Tuberculosis and the Politics of Exclusion (New Brunswick: Rutgers University Press, 2007), 61.
CDC, Trends in Tuberculosis, 2018.
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Figure 2: This is the data presented by the CDC on their webpage titled “Trends in Tuberculosis,
2018” and is placed under the sub-heading “Minority populations continue to be
disproportionally affected by TB disease.”34

Further, it is also important to highlight that for several racial and ethnic minority groups
the burden of TB has either remained stagnant or increased between 2017 and 2018. Khan et al.
found for the past two decades, TB cases have decreased nationally, however, disparities
between who has active TB infection have not. They used rate ratios to assess the health
disparities between various populations in the U.S and found that the case rate for TB decreased
for minority populations as a whole; however, the rate ratios of TB, between 1994-2016, either
increased or stayed the same for all minorities relative to the white population in the USA. 35 The
disparity between white populations and minorities in TB infection did not improve in over two

34
35

CDC, Trends in Tuberculosis, 2018.
Khan et al., “Changes in Tuberculosis Disapirities at a Time of Decreasing Tuberculosis Incidence in the United
States, 1994-2016,” AJPH 108, no. S4 (2018).
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decades. For immigrant populations in particular, the index of disparity by national origin
increased an average of 1.5% per year between 1994 and 2016 indicating that while there has
been progress to decrease TB, immigrants face a disparity with TB infection here in the US. It
would be incorrect to shift all of the blame to the country of origin, rather more focus should be
given to the social and environmental factors here in the US that would increase the risk of
developing TB in the USA for these immigrant populations.
Similar to the CDC, health departments around the country are emphatic that most cases
of TB in the USA are contracted by “foreign born individuals.” Local histories of TB in the US
are also rooted in racism and xenophobia. California, which has 23.2% of all cases of TB in the
US, has a significant history of TB and exclusionary sentiment towards immigrants. 36 Dr. Emily
K. Abel, in her historical analysis of TB in Los Angeles in the early 20th century, provides a
historical context of ideas of racial superiority that bleed into anti-immigrant sentiment. At the
turn of the 20th century, Los Angeles was considered a place where the warmth and the sun
would greatly benefit people with TB. However, the Los Angeles leadership worked to change
this perception because they felt that it was attracting ‘poor’ and diseased people that were
burdening their community. Abel argues that not only was there a growing fear of TB but also a
growing fear of the poor, who were perceived as ignorant and lacking care for public health and
hygiene. 37 For example, in a Los Angeles ad campaign, the intended audience was financially
stable white people from the East coast with advertisements of the real estate and agriculture
industries of California. They marketed that the agriculture in California was disease-free, unlike
the agriculture from other countries, which is already hinting at the assumption that other

36
37

CDC, Trends in Tuberculosis, 2018.
Abel, TB and Politics of Exclusion, 30.
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countries, and therefore immigrants, were carriers of disease.38 Abel argues, however, that the
desire for cheap labor “shattered the dream of racial homogeneity” in California and ultimately
led to the influx of immigrants from abroad. 39 The assumption that the ‘poor’ were too ignorant
to care about public health and were a burden on the “public purse” was an assumption that was
projected onto immigrants as well.
As the migrant population increased, namely immigrants from the Mexico, California
invoked many practices of exclusion with public health officials playing a major role in
encouraging fear of migrant as carriers of TB as well as other diseases in the early 20 th century.
The rhetoric circulating among public health circles was similar to the perception of the poor.
Mexicans were perceived as “dirty,” “incompetent” and reckless in regards to public health
precautions.40 Southern California health officials argued that TB was not part of normal life in
Southern California and then blamed immigrants for the presence of TB. 41 In order to justify
anti-immigrant sentiment, the State Board of Health in California insinuated that TB was
“imported” because “only” 30.2% of cases were native to the US. 42 This seems all too familiar in
the 2018 California TB report which emphasized that 83% of the cases of TB in California were
from people born outside of the US. The board also admitted that over half of these cases
occurred in immigrants, who had arrived in the US 20 years or more prior to falling ill with TB. 43
Given that on average immigrants had lived in California at least 20 years prior to contracting
active TB should be a huge indicator that the context in which immigrants are living in the US
plays a bigger role than their point of origin. Yet, that is not the case in California’s annual TB

Abel, TB and Politics of Exclusion, 62.
Abel, TB and Politics of Exclusion, 62.
40 Abel, TB and Politics of Exclusion, 64.
41 Abel, TB and Politics of Exclusion, 38,62.
42 Abel, TB and Politics of Exclusion, 29, 30.
43 California Department of Health, “Report on Tuberculosis in California, 2018,” 2.
38
39
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reports. Both on the national, the state, and the local level (for New York City), there is a
repeated focus in the modern day on the fact that most TB cases in the U.S are among “foreignborn” individuals, who have live in the U.S for at least a decade. As stated earlier, the incubation
for M.tuberculosis is on average a maximum for two years, so obviously something more is
going on than is reported. There is not proper accountability given to the social context and
injustices that immigrants live through in the U.S that could potentially trigger the activation of
TB, which is a vital component to implement proper interventions to eradicate TB.

Risk Factors and Contextual Triggers for TB
The CDC and local health departments place too much importance on whether a person
was born in the U.S or not and glosses over key risk factors and social-determinants that could
heavily influence an individual’s susceptibility to active TB infection. Abel points out that the
connection between harsh working conditions and higher TB rates in Mexican populations was
notably left out of the public health discourse in California in the early 20th century. She
attributes this to the fact that working conditions of the Mexican population was out of the line of
sight of the health department being a namely white organization. 44 The current public health
conversation does consider the socioeconomic context to some extent. The CDC states the TB
risk factors for people in the U.S. are: people with diabetes; individuals who have excessive
alcohol use; have used noninjectable drugs; individuals who have HIV infection; people who
have reported being homeless in the year prior; and people were live in correctional settings as
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well as healthcare care workers or people who work with groups who have higher transmission
rates of TB.45
However, the CDC does not discuss the socio-contextual that may exacerbate an
individual’s risk of developing TB. Furin, Cox, and Pai, for example, highlight that loweconomic status increases the risk of becoming infected namely due to living conditions. In a
study in Ventanilla, Peru, researchers observed that modifiable risks, that strongly predicted of
TB cases, in the homes were indoor air pollution, limited number of windows per room, and the
socioeconomic status of household. 46Other reports have also stressed the increased risks of
developing TB if an individual is a smoker. 47 However, Furin, Cox and Pai stress that more
research is needed to further understand the human infection model of TB. The human infection
model can expand the understanding of the impact that social and environmental factors have on
the TB infection. While there is acknowledgement of the socioeconomic context in regards to TB
prevalence, at least amongst some academic researchers, there is still significant focus amongst
public health reports on the place of origin of the immigrant rather than the local context in
where they live in the USA. On a global level, The WHO, stated that the most significant risk
factors for TB in 2018 was, in addition to alcohol abuse and smoking was positive HIV-status,
which contributed to 0.81 million cases of TB worldwide as well as diabetes mellitus, which
caused 0.36 million TB cases. 48 The most significant contributor to TB worldwide however, was
undernourishment, which is a risk-factor left out of the conversation surrounding TB in the U.S.
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Food Insecurity as a Risk Factor for Active TB
It is evident that characterizing people with TB by their country of birth is problematic and is
ignoring the root of the structural problems in the U.S that could lead to active TB infection. One
important factor that requires further research is food insecurity. Food security is defined as all
people, “at all times have physical, social, and economic access to sufficient, safe, and nutritious
food that meets their food preferences and dietary needs for an active and healthy life.” 49 Thus,
food insecurity is the opposite and is defined by Feeding America as “ a household’s inability to
provide enough food for every person to live an active, healthy life” and is a way to measure and
assess the risk of hunger.50 The ranges of food security are: high food security, marginal food
security, low food security, and very low food security and they are presented in figure three.
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Figure three: This image shows the levels food security to more accurately describe the
experience of households that range between food secure and food insecure. High food security
and marginal food security are categorized as “food secure” whereas low food security and very
low food security are considered “food insecure.” 51

Undernourishment, a possible result of food insecurity, is a known risk factor for
tuberculosis worldwide. In fact, it is one of the most significant factors in the development of
active TB worldwide.52 In 2018, 2.8 million TB cases were caused by undernourishment. 53
Undernourishment includes a wide range of nutritional deficiencies, and is the most common
cause of secondary immunodeficiency around the world.54 Many animal models have suggested
the extensive impact of undernutrition on the immune response against M. tuberculosis
however, Sinha et al. calls for more research on the impact of undernourishment on the human
immune response to M.tuberculosis.55 M.tuberculosis can also can impact the effectiveness of
the BCG vaccine, the vaccine for TB given to infants in many countries worldwide, and should
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be a consideration in the development of new vaccines for TB.56 Additionally, there is some
research suggesting a correlation between undernourishment leading to more severe TB cases
however, more research is needed to make more definitive conclusions on this correlation. 57
Lastly, undernourishment has been shown to worsen treatment outcomes and the nutritional
status of a patient could act as a predictive measure for the treatment success, outcomes, and
mortality.58 Undernutrition and TB have a cyclical relationship in that undernutrition can weaken
the immune system and ultimately increase an individual’s risk of developing active TB
infection. On the other hand, a symptom of TB is weight loss and a potential consequence for
many with active TB is poverty, both of which are factors that contribute to undernutrition. 59
What is important is understanding the significant influence that undernutrition can have on
contracting active TB infection, TB treatment, and treatment outcomes. According to the US
Department of Agriculture (USDA), in 2018 14.3 million households or 11.1% of households
were food insecure at least once throughout the year in the US. 5.6 million households (4.3%)
had very low food security. 60 Within the context of the US it could be useful to look at the
influence of food insecurity on TB cases given the prevalence off food insecurity has on
households in the U.S each year.
The impact of malnutrition on TB is known and relatively well researched however, there is a
dearth of research on the relationship between food insecurity and TB. 61 Food insecurity in the
U.S. could be a more specific indicator in understanding the groups that are more at-risk of

Pranay Sinha et al., “Undernutrition and Tuberculosis,” 1359.
Pranay Sinha et al., “Undernutrition and Tuberculosis,” 1359-60.
58 Pranay Sinha et al., “Undernutrition and Tuberculosis,” 1358.
59 Pranay Sinha et al., “Undernutrition and Tuberculosis,” 1359.
60 Alisha Coleman-Jensen, Matthew P. Rabbit, Christian A. Gregory, Anita Singh. Household Food Security in the
U.S in 2018, ERR-270, U.S. Department of Agriculture, Economic Search Service, September 2019.
61 Ingabire G. Balinda, Diarmuid D. Sugrue, and Louise C. Ivers. “More Than Malnutrition: A Review of the
Relationship Between Food Insecurity and Tuberculosis,” Open Forum Infectious Diseases 6, no. 4 (April
2019): 1. 10.1093/ofid/ofz102
56
57

23

developing TB, specifically the people who fall into the category of “foreign-born.” Studying
food insecurity in this population is worth the endeavor considering the relationship between
immigrant status, food insecurity, and tuberculosis in Canada. 62 Danielle Burgess, faculty of
Social Work at the University of Toronto, recognized that while immigrants, or foreign-born
people, from high TB burden countries were more likely to develop TB in Canada, this was
largely instigated by social determinants of health, such as stress and poverty that are common
occurrences when first relocating to Canada. 63 In Canada, household food insecurity is more
common for recent immigrants than non-immigrants and can be one of the ‘stressful’ factors that
play a role in immigrants to develop ‘active’ TB. 64 While there is limited information on
specifics related to food insecurity and TB in the US in the official CDC and other state records,
there is still some information in New York City to gain some insight on the role of food
insecurity in the activation of TB in US communities.
In New York City, 84% of TB cases in 2019 were among “foreign-born” individuals, who
had resided in the U.S. for a median number of 13 years.65 Every borough in New York City had
TB cases in 2019 and 15 neighborhoods had a TB rate higher than the city-wide rate with the
following neighborhoods having the most cases: Hunt Point-Mott in the Bronx; Sunset Park in
Brooklyn; and West Queens in Queens had the highest rates.66 Sunset Park and West Queens
also had some of the highest rates in 2018 but Hunt Point-Mott was newly added in 2019. The
TB rate for West Queens also increased between 2018 and 2019. Between 2015-2017 the most
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food insecure bureaus were: Brooklyn, which is home to Sunset Park, a neighborhood with one
of the highest rates of TB in NYC.67

Why is food insecurity so such a significant risk factor for TB?
The relationship between food insecurity and TB is under researched compared to
malnutrition and TB, especially within the US. Balinda, Sugrue, and Ivers published a review
detailing the death of research on the impact of “non-nutritional pathways” on the connection
between food insecurity and TB. 68 The “non-nutritional pathways” are mental health, high-risk
health-related behavior, and substance abuse. The authors found articles that demonstrated the
connection between food insecurity and nutrition as well as the “bidirectional relationship”
between nutrition on TB.69 The “bidirectional relationship” suggests that the symptoms of TB,
such as weight loss, as well as the consequences of TB, such as the financial strain, can result in
food insecurity for individuals with TB. On the other hand, food insecurity can result in
undernourishment or other nutritional issues which has been considered a significant for risk
factor for TB for many decades and was the most substantial risk factor for TB in 2018,
according to the WHO.70 However, Balinda, Sugrue, and Ivers found the connection between
food insecurity, obesity, diabetes TB was less recognized which is important because of the
association of obesity with diabetes mellitus. Diabetes mellitus is another major risk factor for
TB, according to both the CDC and the WHO.71 In fact, according to the CDC, the diabetes was
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the most substantial risk factor for TB in the US with 19.8% of people with TB also having
diabetes.72
Additionally, Balinda, Sugure, and Ivers found that food insecurity and mental health was
relatively well researched as well as the connection between TB and mental health however,
once again there was not any studies on the connection between all three. Studies have found a
correlation between food insecurity and depression, PTSD, stress, shame, and anxiety.73 The
authors found studies on the association between TB and stigma. Stigma can result in
internalized guilt, shame, and disgust which may contribute to depression which in turn can
impact a individuals’ likelihood of seeking a diagnosis and also is more likely to result to
treatment non-adherence.74 Many of the individuals who have TB and who discussed their
“personal stories,” as presented by the CDC, had a similar feeling of stigma surrounding their
diagnosis in the U.S.75 Many discussed how the stigma was rooted in ignorance in that others
were unaware of the symptoms of TB and how TB is transmitted. So the association between
stigma surrounding TB and the mental health consequences are relevant within the U.S. While
studies were available that highlighted the connection between food insecurity and mental health
as well as the impact of stigma with TB on mental health was available there was a dearth of
research on the connection between how mental health, food insecurity, and TB are all
connected.
Lastly, Balinda, Sugure, and Ivers researched what is known of food insecurity and TB
and their impact on health-related behavior and substance abuse. Food insecurity places
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“individuals and families in a precarious situation that can influence their decision-making and
tolerance of risk, which can have important health implications.” 76 The connection between food
insecurity and postponing medical care, postponing medications, utilizing the emergency
department use, and hospitalizations has been studied as well as the impact of food insecurity’s
negative impact on treatment adherence. 77 Balinda et al. found many studies conducted in
various countries in which food insecurity impacted TB treatment adherence as well as the
impact of food insecurity and substance abuse disorder as well as excessive alcohol use.

78
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abuse of alcohol and substance-use disorder are considered major risk factors for TB both
globally and within the U.S.79 Balinda et al. found studies highlighting the connection between
food insecurity and the correlation with increased alcohol and drug abuse as well as the strong
association between alcohol and IV drug use with pulmonary and active TB, respectively.80
Balinda et al. hypothesized that “food insecurity is part of a negative cycle within households
that leads to increased TB disease and poor outcomes through nutritional, mental health, and
behavioral pathways” and concluded that there were hardly any studies indicating these
connections and they call for more research on this hypothesis.81 The connection between food
insecurity and TB could be substantial and is an important risk-factor to consider within the U.S.
14.3 million households in the U.S were considered ‘food insecure’ and 5.6 million of those
households were considered to have very low food security. 82 Food insecurity is not an unknown
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phenomenon in the U.S and the connection between the two is important consideration and topic
of research in high-burdened TB communities in the U.S. that requires further research.

Financing TB in the United States
The presentation of data is more significant than just for TB advocacy and reports of
burden but also, becomes the basis for funding requests. The purpose of this section is to discuss
the budget provided for TB domestically and their reasoning, based on the CDC’s justification,
for this funding. The budget justification provides insight on what TB strategies are utilized in
the US and what strategies are receiving funding. Domestic funding for TB is primarily
distributed to the CDC by Congress and so the CDC’s justification for the requested funding
gives a sense of how the CDC is responding to TB and how the categorization of “foreign-born”
influences funding and policy. While the US does have a relatively low number of TB cases per
year, the CDC stated that in 2019 the “current strategies” to combat TB in the US were “not
enough to eliminate TB in this century.”83 It is likely due to both inefficiency in domestic TB
programming and underfunding TB efforts. In regards to what programming receives TB
funding, there is not any mention of programming specifically for “foreign-born” individuals,
who bear the brunt of TB cases in the US despite this association being repeatedly emphasized in
advocacy efforts and reports. Also, there is not any mention of funding for social-contextual
factors or social determinants, such as food insecurity, within the justification. While the CDC
emphasized their concern that current strategies are not enough to eliminate TB, these
“strategies” go beyond limited funding but also includes how they approach and advocate for TB
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too meaning that without more substantial strategies to combat social determinants for “foreignborn” people specifically, then TB will not be eliminated.
The total budget for TB provides a bigger picture of how much is provided for TB
funding and what aspects of TB control and prevention are provided funding. For the FY 2021,
the CDC was provided $135 million for TB domestically and accounts for 11% of the sector’s
budget.84 TB is funded through the “HIV, Viral Hepatitis, STIs, and Tuberculosis” budget for the
CDC which is presented in figure 3. While it is, at least, reassuring that the domestic budget for
TB did not decrease, between the FY 2020 and 2021, it is nonsensical that tuberculosis would
not receive more funding given that the CDC did not believe that the recent strategies for TB in
the US would result in TB elimination in this century.

FY 2019 Final

FY 2020
enacted

FY 2021
President's
Budget

FY 2021/
FY 2020
Enact

Total Budget for “HIV, Viral
Hepatitis, STIs, and
Tuberculosis”

$1,123.89

$1,273.56

$1552.556

$279.00

Budget for Tuberculosis Only

$134.55

$135.03

$135.034

$0

Figure 3: Federal Funding for the CDC is separated into sectors. TB is funded under the “HIV,
Viral Hepatitis, STIs, and Tuberculosis” sector. This figure presents the budget for this sector
and specifically the CDC’s budget for TB domestically in the fiscal year 2021. 85 All monetary
values are in the millions.
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The $135 million for TB goes towards the following: investment in health departments to
improve TB control and prevention; to provide training and laboratory services for health
professionals and health departments nationwide; to fund TB clinical and field research for
improved treatment regimens and improved LTBI prevalence estimations; and funding for
programs related to improved preparedness for TB at the national level. 86 The budget
justification does not emphasize the social-determinants of health within TB programming but
rather focuses on the development of TB treatment and then TB control more broadly. While
both of these components are important to TB control and elimination there is a lack of
importance placed on the social determinants of health related to TB. Moreover, there was an
emphasis on the treatment of LTBI within the budget justification which relates to the emphasis
on “foreign-born” people constitute the majority of TB cases. The importance placed on foreign
birth insinuates that these individuals were mostly infected elsewhere and imported latent TB
infection (LTBI) from their country-of-origin to the US and the LTBI it activated once in the US.
So, the implementation of more widespread LTBI treatment likely targets this population;
however, that is not explicitly stated in the justification.
In the budget justification, the CDC noted that in the US, there were 9,029 cases in 2018,
which is relatively low. However, they estimate that up to 13 million people in the US have
latent TB and estimate that “more than 80% of the U.S. TB cases result from reactivated latent
tuberculosis infection (LTBI).”87 Yet, Behr et al., who concluded that the incubation period for
M.tuberculosis is maximum two years on average, also found that the reported burden of latent
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TB worldwide is ‘overestimated.’ 88 Both of these findings are substantial in regards to TB
initiatives and strategy within the US because the main strategy of the CDC, regarding TB, is
the prevention of “reactivated LTBI”. However, Behr et al. determined that the number of latent
TB cases globally is ‘overestimated’ because “ it reflects immunoreactivity to either past or
present infection.” 89 Immunoreactivity means that someone with M. tuberculosis, latent or
active, or someone who has been infected with M. tuberculosis previously has adaptive
immunity with or without the presence of M. tuberculosis. These individuals may test positive on
a tuberculosis skin test (TST) however, the positive does not always mean that the
M.tuberculosis will activate because the positive test could indicate both the presence of LTBI or
a previous infection of LTBI or active TB infection. So, in accordance with the findings of Behr
et al., who found that the global latent TB burden is ‘underestimated,’ there is reason to think
that the US estimate for the number of LTBI, that could develop into active TB, is lower than
was once thought. The expansion of LTBI treatment speaks to a broader issue in which the
CDC’s response to the disproportionate burden of TB cases in the “foreign-born” population is
the expansion of LTBI treatment without any recognition of programming that focuses on the
underlying social-contextual factors that contribute to the activation of TB. The ‘solution’ then
still implies that the blame for TB is the country-of-origin, rather than addressing the structural
issues in the US that contribute to TB cases among immigrants.
Additionally, within the budget proposal, the CDC did not mention the “foreign-born”
population but rather included a performance summary that stressed their work towards the
“Long Term Objective” to decrease the rate of TB among “U.S. born persons in the United

88
89

Behr, Edelstein, and Ramakrishnan, “Revisiting the Timetable of Tuberculosis,” 3.
Behr, Edelstein, and Ramakrishnan, “Revisiting the Timetable of Tuberculosis,” 3.

31

States.”90 Even though the CDC states in reports and advocacy materials that the majority of TB
cases in the US are among “foreign-born” people, that language is nowhere in the budget
justification to Congress. The word choice is significant because while the “foreign-born”
population is disproportionately impacted in the US the goal, or at least the goal presented to
Congress, is to protect “US-born” individuals. Potentially this change in data presentation by
focusing on the impact on “US-born” people is a way that the CDC can receive more funding
from Congress. This is still highly problematic because in the CDC’s advocacy for TB and their
reports on TB burden, they collect and present data that shows that “foreign-born” individuals
make up most of the TB cases which implies that these individuals were infected with TB
elsewhere, namely their country of birth. However, they do not collect and present information
related to social-contextual issues, such as food insecurity, as related to TB, which might be a
better indicator of the burden of TB, rather than the birthplace of patients. By then advocating on
behalf of “US-born” individuals in the budget justification, who are not as significantly
impacted, the CDC is complicit in xenophobic and racist policies that look at immigration-status
rather than the structural factors at play in the US that contribute to higher TB rates. The CDC
does not challenge the structural issues associated with potential risk of TB and so this could be a
challenge in their effort to eliminate TB in the US.
Link with neoliberal and is the same in global financing
While the burden of TB burden is relatively low rate in the United States, the CDC
proclaims that “current strategies are not enough to achieve TB elimination in this century.”91
Limits on current TB strategies go beyond funding but is also influenced by the CDCs response
to the TB burden in the US. The emphasis on a higher TB rate among individuals with “foreign-
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birth” vs. individuals does not acknowledge the impact of structural factors, such as food
insecurity, on TB prevalence. Rather, this emphasis perpetuates xenophobic policies where CDC
is perceived as a disease imported from elsewhere and then funding for TB is justified based on
the extent that it helps and protects US born people. Stigmatizing immigrants as being more
prone to infectious disease or carriers of disease is dangerous because it “ serves political
purposes by justifying restrictive immigration policies that ignore broader structural
conditions..[and] underlying disease transmission.”92 Also, the lack of focus on social
determinants, like food insecurity, is rooted in neoliberal ideology by focusing on birth place
rather than acknowledging systemic issues that are in need of adjustment. The choices of what
data the CDC chooses to present to exhibit the burden of TB in the US influences how the
burden is perceived and then how the CDC responds. The lack of attention given to structural
issues such as food insecurity is embodied in the global financing for TB as well.

Overview of Global Financing for TB
This section shifts the focus of the paper from domestic TB efforts within the US to
global TB efforts and the role of the US in these efforts. Before looking more into the US global
TB efforts, it is important to understand the global context of these efforts. While global health
efforts often do not receive adequate funding, TB specifically has a history of being ignored.
According to the Institute for Health Metrics and Evaluation (IHME), between 1990 and 2018,
tuberculosis received the second lowest amount of development assistance for health (DAH) at
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$19.9 billion.93 In 2019, $6.8 billion USD was put towards TB efforts globally. This is around
$3.3 billion short of the financial goal of the WHO. 94 $5.9 billion, or 87%, of funding for TB was
from domestic resources. The BRIC (Brazil, Russia, India, China, and South Africa) countries,
where 47% of the world’s TB cases occurred, accounted for 53% of the available funding. 95 For
other LMICs, namely low-income countries, international donations are more common and
necessary, with 49% of funding for TB originating from international donors. 96 The United
States has been the largest contributor to global TB efforts; however, international donations,
from the US and other countries, have been dropping in recent years. The decreasing political
will of the US, as well as the distribution of global funding, which is discussed later on, suggests
a lack of interest in investing in global health efforts which consequently lessens investment in
TB efforts not only related to treatment and vaccines but also decreased the possibility of
funding programs that focus on systemic issues, such as food insecurity and undernutrition
worldwide and domestically, which is already underrecognized in TB programs.

The United States
Historically, the United States has been, and continues to be, the largest country donor for
global TB efforts. It provided $578.6 million for tuberculosis in 2018. The US channeled $236.6
million USD through NGOs, $182.4 million through the Global Fund, and $141 million through
its own agencies.97 However, for the FY 2019, the United States budgeted only $306 million and
the Trump administration’s requested amount for TB funding in FY 2020 dropped even lower to
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$262 million.98 The drop in funding is once again nonsensical considering the WHO stressed that
the global shortage of $3.3 billion USD to combat TB.99 The United States distributes its funding
for TB through different channels which are exhibited in the figure four.100 Similar to the CDC’s
domestic TB efforts, global tuberculosis funding and foreign US aid is carried out within the
framework and ideology of neoliberalism.

United States Funding Channels for TB Globally

24.40%
40.80%

31.50%

NGOs

The Global Fund to Fight AIDS, Tuberculosis, and Malaria

U.S. Agencies

Figure 4: The figure indicates the channels in which TB funding is distributed. Note that the
most funding is channeled through NGOs and The Global Fund which shows neoliberal
realignment of global health efforts from efforts carried out by state to global health efforts being
carried out mainly by NGOs. The Global Fund provides the most global funding towards TB and
accounts for 73% of global financing for TB from international donors. 101 Yet, only 15.8% of the
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Global Fund’s budget went towards TB, at $6.78 billion in 2018.102 This data is from the IHME
at the University of Washington.103

Overview of Neoliberalism in Global Health
The influence of neoliberalism in TB efforts, as well as all global health efforts, is
significant because it influences the focus on TB efforts that provide direct profit rather than
funding programs that provide systemic change. The priority within the framework of
neoliberalism is profit as so neoliberalism within global health prioritizes investment in products
with immediate profit such as drugs, diagnostic technology, and vaccines. While these
developments are important in global health and TB efforts, they tend to be the general focus
while more systemic issues, such as food insecurity or undernourishment, which can
significantly impact an individual’s susceptibility to TB, are not addressed as significantly. Dr.
Salmaan Keshavjee, professor and the Director of the Harvard Medical School Center for Global
Health Delivery, discusses this phenomenon in Blindspot: How Neoliberalism Infiltrated Global
Health. He explains that the golden rule of neoliberalism is “he who has the gold, rules” and the
market rules all.104
In the midst of the 20th century, the neoliberal ideology took course and NGOs became
responsible for providing for services to the poor rather than the state.105 The transferal of duties
was justified in an effort to combat communism and totalitarianism by limiting state functions.
Keshavjee further explains that moving NGOs to the center of international development and
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global health shifted the ideal from the ‘welfare state’ to the NGOs which have become the
“transplantation mechanism” for neoliberal ideology. 106 Figure 4 demonstrates this phenomenon
and shows that US foreign aid for TB is distributed namely through NGOs and the Global Fund.
Keshavjee argues that the neoliberal ideology is creating a ‘world order’ and important
components of the ideology, such as free market, utilization of NGOs etc are “operating as
common sense,” meaning that neoliberalism is so pervasive that all efforts that operate under this
framework are shifting the idea of what is considered the ‘correct’ way to respond to global
health issues, such as TB. Keshavjee argues that neoliberal goals of profit, open market lead to
“neoliberal programmatic blindness: areas of programs that are eclipsed by ideological aims.”107
This is explains why in the US, the CDC focuses on “foreign-birth” of a TB patient as the most
notable factor in the development of TB rather than acknowledging and addressing the social
determinants that influence TB incidence. For the US global efforts, United States Agency for
International Development (USAID) distributes funding to international organizations and other
programs for TB global interventions and is heavily guided by neoliberal principles.

USAID
In 1998, USAID, the main agency that carries out global TB initiatives for the US, began
a global TB program and has been the single largest donor to the Global Fund by providing more
than $930 million between 2010 and 2014. 108 However, USAID was created by John F. Kennedy
in 1961 with the intent of creating foreign development programs that would benefit the US
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politically and the western world ideologically.109 Dr. Keshavjee argues that it was clear that that
in USAID in Almaty in October 1996, when asked about their reasoning to finance a revolving
drug fund, was to “to open new markets” and “foster democracy.”110 The language is extremely
similar in the USAID budget and goals for 2021. The USAID budget for global TB the FY 2021
is $275.0 million. Within their justification for funding, USAID included that they “support a
competitive market for quality-assured TB and MDR-TB drugs, as well as diagnostics and other
commodities, including through the innovative Global Drug Facility.” 111 The importance of the
goals to open up markets and support the production of diagnostic tools, drugs, and vaccines all
of which contribute to the ‘market.’ While these tools do hold importance in the elimination of
TB, the importance of social determinants of health or more systemic change, such as efforts
responding to the relationship between food insecurity and TB, is not emphasized, most likely
because it does not contribute to immediate profit.
The USAID also started a project called the Global Accelerator to End Tuberculosis and
the language used in the report to Congress is that it is the “agency’s new business model for
TB.”112 The language of ‘business model’ suggests the undertones of neoliberalism and the
ideology is further emphasized in the USAID FY 2019 Financial report. In this report, USAID
detailed their strategic goals. One of the goals involving health was strategic objective two,
which was to “renew America’s Competitive Advantage for Sustained Economic Growth and
Job Creation.”113 A subset objective two was strategic objective 2.2 which is to “Promote
healthy, educated, and productive populations in partner countries to drive inclusive and
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sustainable development, open new markets, and support U.S. prosperity and security
objectives.” 114 So obviously, neoliberalism is guiding the framework of the main agency that
conduct global TB initiatives from the USA. For advocates of neoliberalism, success means the
creation of markets and reduction of government involvement in the lives of citizens.115 USAID
is straightforward in strategic goal 2.2 to opening new markets. Neoliberal ideology emphasizes
profit over everything and contributes to the lack for attention provided to social determinates of
TB both domestically and globally.
Burgess (2016) suggested a similar phenomenon when arguing why food insecurity is not
stressed in TB initiatives in Canada. She argues that the “work-first models” developed in the
U.S in the 1980s and ‘90s led to many countries, including Canada, to shift to similar models.
The “work-first” model shifted the focus of the social welfare system to emphasize “rapid laborforce attachment” meaning that employment trumped “any other welfare objective, including
health.”116 She noted instances when doctors advocated for higher welfare checks for low income
families since the amount provided was too low to purchase healthy food and was rejected
because “A doctor is there to be a doctor, not an advocate for the poor.” 117 Like Canada, the lack
of connection perceived between medicine, public health, and social welfare in reflected in the
priorities of the CDC and USAID, and is a reason why issues such as food insecurity, are not
given the same funding or recognition as drugs or vaccines in the fight against TB both
domestically and globally. The following section discusses the program areas of TB funding and
show the limited funding going towards structural inequality.
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Program Area of Global TB Funds
Of the $6.8 billion USD in funding for TB in 2019, $4.3 billion was for drug-susceptible
TB and $2.2 billion was designated for multi-drug resistant TB. The remainder was put towards
interventions related to the TB/HIV co-infection.118 The median cost to treat a patient in 2018
with drug-susceptible TB was $973. Treatment for a patient with MDR-TB was $6430.119 The
dispersal of funds was $162.1 million, or 9.9%, for the development assistance of health for
treatment of TB and $32.9 million, or 2.0%, for diagnosis.120 Many reports indicate that this is
not enough. In particular, MSF reported that there has been a yearly $3.5 billion funding gap for
TB treatment and diagnosis and $2 billion annual funding gap in TB research. 121 While the
funding gaps for TB treatment and diagnosis are significant, the funding gaps for social
determinants of health are not clear or even detailed in the global TB reports. It may be easier to
quantify the funding gaps for research, treatment, and diagnosis however, it is equally as
important to know where the world stands on interventions related to more structural issues
related to TB. Figure 6 highlights the funding dispersal by program area for TB in 2018. TB
diagnosis is provided the most funding followed by human resources, other health system
support, treatment, ‘other,’ and then drug resistance. It is unclear what ‘other’ represents.
Perhaps, it is funding for other developmental related funding for TB, which relates to food
security and economic stability but that is not substantiated within any of the reports.
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Global TB Funding: Program Area Dispersal in 2018
$37.50
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$218.8

*In USD billion
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Figure 5: The most funding goes towards TB diagnosis at $162.1 million or 9.9% DAH
for treatment of TB and $32.9 million (2.0%) for diagnosis. Data provided by the IHME from
global health financing in 2018.122

Growing Disinterest in Foreign Aid
While there have been global efforts to combat TB, such as the UN meeting in September
2018 which was the first UN high-level meeting for TB, there is a growing disinterest by
governments to provide money for foreign aid, in general. Médecins Sans Frontières (MSF)
released a report documenting and warning the world of the waning interest and commitment to
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both HIV/AIDS and TB.123 Between 2017 and 2018, international assistance decreased by 9%
and 12% for HIV/AIDS and TB, respectively. 124 In 2018, the development assistance for health
for TB was $1.6 billion which was down 12.2% from 2017.125 and TB still only remains 4.2% of
total DAH funding for all health areas.126 While there has been much improvement in the
attention and funding given to TB in the last couple of decades, international organizations stress
that it is not enough. Funding for TB has never reached the threshold to SDG goal to end TB by
2030, and so decreasing efforts and funding for TB now is a mistake.
High-income governments are not putting forth the funding necessary to eliminate the
threat of TB. The United States is an example of waning government interest in foreign aid. Not
only is the US diminishing foreign aid, but it is not even providing enough funding for TB
domestically. For the FY2020, the US funding for TB global initiatives was cut by 14% and
contributions to the Global Fund were cut to $958 million, the lowest since 2007. 127 TB and
HIV/AIDS both burden LMICs most significantly and so global collaboration is vital for the
eradication of either to be possible. MSF explains that this lack of funding is placing an
increased burden on already strained health systems and infrastructures. 128 Additionally,
Andrew Price-Smith, a political scientist, stresses that “dealing with the proliferation of so many
diverse pathogenic agents will require enormous amounts of political will, international
cooperation, continued regime consolidation, and a significant redistribution of resources” from
high-income countries to LMICs. 129 Less global funding increases the likelihood that multidrug
resistant TB (MDR-TB) will become more of a threat and the Sustainable Development Goals
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(SDGs) to eliminate TB and HIV/AIDS by 2030 is growing increasingly unlikely and resulting
in both diseases becoming more of a risk for everyone.130 Price-Smith also explains that attrition
outbreaks, such as HIV and TB, “don’t generate as much fear and out-migration as ‘outbreak
events’ but they typically result in greater actual human morbidity and mortality and in
significant long-term economic and social erosion.”131 Price-Smith explains why less attention
given attrition outbreaks, such as TB, can be detrimental to societies. The lack of perceived
urgency could be playing a role in decreasing funding but also, in the case of the US, increasing
isolationism and anti-immigrant sentiment is leading to disinterest global collaboration.
In the US, the current government is isolationist with pervasive anti-immigrant polices
and rhetoric which filters into global health efforts and TB efforts both domestically and abroad.
The CDC plays into this anti-immigrant sentiment with their emphasis on “foreign-born” people
accounting for the most cases of TB in the US without acknowledgement of the social-contextual
risk factors for immigrant in the US that may contribute to TB activation. The association
between “foreign-born” and TB pushes the blame onto the country-of-origin rather, then looking
at the US context. This is doubled down in the CDC budget justification for congress with
emphasis on TB efforts protecting “US born” individuals from the scourge of TB. The
association of TB being a disease that is caused by people immigrating from outside of the US
might lead to less interest in funding TB efforts globally because it is considered an ‘outsider’
problem without any acknowledgment that global health efforts elsewhere impact the health of
the US population.
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Similar to why the US efforts to eliminate TB domestically are failing, there is a similar
failing globally because of increasing disinterest in foreign aid as well as general disinterest in
funding efforts that improve systemic issues, such as undernourishment and food security, which
are significant risk factors for TB. While there is increasing disinterest to fund all global health
initiatives, this is not a new phenomenon for TB. McMillen explains that throughout the 20th
century, there has been ebbs and flows of the global attention provided to TB in which the world
has been continuously “discovering and rediscovering” TB. 132 Drug-resistant TB and the
HIV/TB co-epidemic has reintroduced the threat of TB to higher income countries even though,
as McMillen argues, these issues are not new since “TB is not newly out of control; it’s never
been under control.” 133 The fact that TB has never not been an issue for many parts of the world
shows, and is still an issue in the US, speaks to the importance of data collection and
presentation in developing priorities in global health. The US still had thousands of TB cases per
year; however, it is presented as a disease that impacts “foreign-born” people the most which
plays into the decades-long assumption that TB was ‘fixed’ and resulted in decades of ignoring
TB worldwide. The disinterest in funding TB leads to consequences worldwide because global
health efforts, for better or for worse, are dictated by the high-income country agenda and
funding that is monopolized by higher-income countries. This calls back to the golden rule of
neoliberalism which is “he who has the gold, rules” 134 Global TB initiatives are dictated by the
whims of political fervor of higher-income countries so decreasing interest can be have global
consequences and leaves certain regions of the world increasingly vulnerable to TB.
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Neocolonialism in Global Health
Most of the money and decision making occurs in higher-income countries; however, TB
burdens LMICs most heavily. In the WHO’s Global TB report, 44% of TB cases occurred in
Southeast Asia and 24% of cases occur in Africa. 135 India, China, Indonesia, the Philippines,
Pakistan, Nigeria, Bangladesh, and South Africa account for 76% of the globally total. 136 While
only 3% of cases occurred in Europe or the Americas, most of the funding distribution, decision
making, and research is conducted in these countries.137 As stated prior, USAID and the Global
Fund are the largest financial providers for TB, both of which are located in higher income
countries, the United States and Geneva, Switzerland, respectively.
There is a plethora of research and articles written on the imperialism of global health.
Tucker and Makgoba (2008) argue that diseases that predominantly impact African populations
such as TB, always receive a small proportion of global financial support for medical
interventions and scientific advancement. Further, they argue that African experts have limited
executive authority in the public-private partnership paradigm of global health. 138 Rose Mbaye et
al. have similar conclusions on the lack of representation of experts from Africa in infectious
disease research conducted in Africa. They conducted a systematic review and found that 93.2%
fit “inclusion criteria” by having at least one Africa-based authors; however, only 49.8% had an
African expert as the first researcher and 41.3% of publications had an African researcher as the
last author.139 Additionally, most first and last authors were from only six countries on the
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continent: South Africa, Ethiopia, Nigeria, Kenya, and Ghana. 140So there is a lack of research
conducted in many parts of the continent. Mbaye et al. ask an important question of “Who is
telling the story?” which asks more questions regarding data collection and presentation of TB.
Similarly, in a recent article, researchers found that experts from LMICs, particularly
who are women, are underrepresented in the leadership of global health journals. In the top
global health journals, experts from LMICs, particularly female experts, are in the minority on
the leadership boards. All of the top global health journals are located in higher-income countries
and are entangled with “colonial structures and power dynamics, where high-income country
experts and institutions are valued much more than expertise in low-income and middle-income
countries.”141 On the boards of 12 major global health journals, 35% of all the editors were
female. 33% of the editors were based in LMICs and only 11% were women based in LMICs.142
Not only are the research journals led by experts from high income countries but also global
health conferences, agencies, and funding is dictated by the agenda of experts in high-income
neocolonial and neoliberal powers. Overall, there is a lack of representation of experts from
LMICs in global health decisions and research which surely contributes to the limited priority
given to TB as well why TB initiatives prioritize increased drug production and vaccine
development rather than food insecurity, for instance, because high-income countries have
financial incentive for pharmaceutical and vaccine development.
The implications of not having enough representation from LMICs has historical roots
but also philosophical explanations. Given that TB and other global health issues are in fact
global, it is important that the perspectives from certain countries, regions, or cultures are given
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priority over another. Seye Abimola (2019) wrestles with positionality in global health
authorship and the role of the ‘foreign gaze.’ 143 Seye Abimola defines the ‘gaze’ as who the
imagined audience is and that is coupled with the ‘pose’ which is “the position or standpoint
from which we write.” 144 This idea is relevant in discussions surrounding what aspects of TB are
provided funding. The prioritization of funding vaccine and drug development can be attributed
to the neoliberal “gaze” in this instance and adds on to Keshavjee’s idea around “neoliberal
programmatic blindness” 145 where neoliberal ideology prioritizes profit over all rather than
funding programs that respond to structural issues that contribute to TB, such as food insecurity
and undernourishment.
Abimola delves into three overarching questions: what if the foreign gaze is necessary?; what
if the foreign gaze is inconsequential?; and what if the foreign gaze is corrupting?. Depending on
the context, the foreign gaze can be all three. This connects with Foucault’s framework for the
medical ‘gaze’ in which Western medicine is based. 146 The ‘gaze’ is the doctor’s perspective and
instills a power-dynamic in which the doctor is superior to the patient. The ‘gaze’ acts, at its
worst, as superior knowledge in which the patient does not have agency in their treatment. The
‘gaze’ dehumanizes the patient and does not consider the context of each individual. This
philosophical framework relates to the ‘foreign gaze’ or the ‘neoliberal gaze’ whose objectives
are to enhancing capabilities for profit rather than working on solutions that respond to social
determinants of TB. Abimola argues that there will always be a difference in what the local and
foreign gaze see. The ‘foreign gaze’ represents neoliberal and neocolonial l powers, who dictate

Seye Abimbola. “The foreign gaze: authorship in academic global health.” BMJ Global Health 4, (October
2019).
144 Abimbola, “The foreign gaze,” 1.
145 Keshavjee, Blind Spot, 114.
146 Michel Foucault, The Birth of the Clinic: An Archaeology of Medical Perception (New York: Vintage Books,
1994).
143

47

the global health agenda and priorities. Abimbola says that “what gets written for the foreign
gaze reflects the appetite of the foreign gaze, which is more attuned to the ‘surgical’ than the
‘organic.’”147 The surgical is tangible and short term change while the organic is the long term
and internal change. Abimola provides a philosophical framework to explain the in neoliberal
influence in TB global initiatives in that they are focus on the ‘surgical’ which is short-term
tangible change via drug and vaccine development. Whereas the ‘organic’ exemplifies TB
interventions that work on the reform of structural issues that will lead to long-term solutions not
just for TB but other diseases, as well.
Abimola concludes that in the globalizing world the foreign gaze cannot be eradicated but
there must be more open conversations on its place in the conversation and that local knowledge
must be valued in order to dismantle colonial structures and attitudes. 148 The same can be said of
the ‘neoliberal gaze.’ Neoliberalism is at the heart of global systems; however, there must be a
conversation discussing its blind spots in regards to global health interventions, especially for
TB. The neoliberal ‘gaze’ encourages the development of drugs and vaccines for TB, which are
important innovations, but their development does not squash the need for structural reform that
contribute to systemic change, such as on efforts to combat food insecurity that surpass just the
availability of food banks or donations, that influence TB prevalence worldwide. Investing in
structural reform is not only useful in the fight against TB but also in all global health efforts.
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Who “deserves” care?
Many of the questions in this paper can be narrowed down to who has been considered
‘deserving’ of care and priority, both in the US but also globally. At the turn of the 20th century
in the USA, there were arguments over how deserving poor TB patients were of medical care
and there was a prominent attitude of disregard for the lives of the poor. The poor were perceived
as “extremely careless about safeguarding the health of others ” as well as economic burdens
because TB greatly exacerbated the impacts of poverty. 149 A NYC medical officer considered
poor people not worth the expenditure because they were “worthless to the community” 150 There
was a similar sentiment among many California officials, who conflated the worth of individuals
to their productivity and social worth, which was essentially eliminated if someone were to get
TB. 151 The concept of social worth is relevant today within the modern neoliberal paradigm
where productive labor and profit are of the utmost importance above all.
In the turn of the early 20th century, immigrants were also considered not ‘deserving’ of
care. Immigrants were considered burdensome and a danger to others, especially when they were
perceived to be carriers of TB. Government officials in California worked to ban and ‘send back’
the migration of the poor and those who could potentially bring TB. In LA, Dr. John L Pomeroy,
the Chief Health Officer of Los Angeles County TB program in 1917 emphasized that Mexicans
and Japanese, who were considered more ‘at-risk’ of TB, were out of the body politic and “their
health was significant only insofar as it threatened that of whites.” 152
The disregard for the lives of the ‘other’ and insistence that it is the fault of the ‘other’
that they fall ill with TB, is not an idea that is easily forgotten. In fact, it is still present in public

Abel, TB and Politics of Exclusion, 32.
Abel, TB and Politics of Exclusion, 34.
151 Abel, TB and Politics of Exclusion, 32.
152 Abel, TB and Politics of Exclusion, 66.
149
150

49

health initiatives domestically and also abroad. The intense focus on country of origin by local
health departments and the CDC indicates that there is much work that needs to be done for TB
eradication.

The Consequences of Not Prioritizing TB
Mobilizing resources to eradicate TB is not only based in a moral argument of human
rights but also can be argued from a standpoint of national security and economics. It is
enormously costly to not eradicate TB. This is namely an issue for high-income countries which
have a history of ignoring TB, which has largely effected them less in the last several decades.
Price-Smith in The Health of Nations, provides a theoretical framework on the impact of
infectious disease on state capacity. State capacity includes the following components which he
argues are from most to least importance: fiscal resources, human capital, reach and
responsiveness, resilience, legitimacy, autonomy, coherence, instrumental rationality.153 He
provides some statistical analysis suggesting that HIV/AIDS and TB, both of which significantly
impact one’s life expectancy, will “exert significant negative pressures on state capacity at the
national level.”154 In research conducted on the US, TB data between 1950-1991 Price-Smith
found a significant negative association between TB and state capacity over time meaning that as
TB incidence fell over 40 years the state was able to work at increased capacity.155
TB is enormously costly for both the individual and the health system. The IHME
institute estimates that if trends of mortality and infection continue, 2.6 million people will die
each year of drug resistant TB by 2050, which will cost the global economy an estimated $16.7
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trillion.156 In 2018 alone, TB cases in the USA cost $480 million to the US.157 Price-Smith
explains a theory of the economic and political impact of an infectious disease resurgence, in any
nation. He argues that it will spur a shock in both the supply and the demand of the healthcare
sector. The demand for medical care will dramatically increase, medical professionals will be at
more at risk, it will burden medical insurance, disability payments, life insurance premiums and
it will add to the societal burden of health care.158 Price-Smith argues that it will likely divert
fiscal resources from the government, causing more deficits and debt, and could lead to the
undermining the ability of a government to provide basic needs to their population. 159 One of
these needs might be food security which may dramatically impact the burden of TB in nations,
such as the U.S. that have comparatively low rates.
Another consequence of an infectious disease outbreak, such as TB, is the impact on food
security. TB, in particular, burdens societies reliant on manual labor for agriculture and food.160
Diseases, such as TB and AIDS, “have significant deleterious effects on the quality of life of a
populace—effects that are reflected in declining life expectancy and increasing in poverty.” So,
not only is the fight to end TB rooted in human rights and injustice but it is one of survival. TB
has largely been underfunded and under researched within the last several decades however, TB
is mostly treatable and arguably, preventable, with appropriate structural interventions. It is
imperative now more than ever that TB be provided the appropriate interventions, especially in
regards to significant structural change, so that it is no longer a threat.
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Global Goals for TB: Are they in reach?
There has been more acknowledgement by the global community about the burden of TB
globally however, it seems that acknowledging the issue has not translated into adequate
resource mobilization. In September 2018, the UN had the first high level meeting on TB and
they introduced and added on to the End TB Strategy’s goals. The goals were that the incidence
of TB should fall 2-5% per year by 2020 and then to 10% per year by 2025. Also, the proportion
of people with TB who die should decrease to 6.5% of all cases by 2025.161 The UN claims that
in order to reach these goals the initiative needs to mobilize at least $13 billion annually for TB
treatment, diagnosis, and treatment and $2 billion per year for research by 2022.162 The Stop TB
Partnership’s Global Plan to End TB 2018-2022 estimates that $10.1 billion USD is required in
LMICs in 2019 and will rise to US $14.9 billion in 2022 to combat TB. In 2019, however, these
financial goals were not met. The WHO collected data from 119 LMICs, which accounts for
97% of notified TB cases, and reported that only $6.8 billion USD was available in 2019. 163
While this is an improvement from the $3.5 billion available in 2006 there is still a gap of about
$3.3 billion USD in 2019 and the WHO calls urgently for more funding from domestic and
international donors.164
The UN suggested that these goals can only be achieved with universal healthcare (UHC)
and with initiatives that focus on systemic issues such as social and economic development. 165
UHC means that everyone can obtain health services without suffering financial hardship. The
WHO explained that faster reduction in incidence and deaths from TB requires improving access
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to diagnosis and care within the overarching global goals of UHC as well as further
understanding the determinants of TB incidence such as undernutrition, poverty, smoking, and
diabetes. These five determinants greatly exacerbated the risk of developing TB. In 2018, 2.8
million TB cases were caused by undernourishment; 0.86 million, mostly men from smoking;
0.83 million due to alcohol abuse; 0.81 million due to HIV status; and 0.36 million from
diabetes.166 The WHO stressed that these issues must be addressed, including poverty levels, in
order to improve TB which is hugely significant for the burden of TB in the US.
Financing TB research and development is essential in achieving TB goals. The UN meeting
called for $2 billion USD to be mobilized annually between 2018-2022 for research. WHO
declares that there must be major technological breakthrough by 2025 so that the TB incidence
rate will fall 17% per year between 2025 and 2035. 167 The top priorities are a new vaccine or
drug treatment for people with latent TB; rapid diagnosis at point of care; safer, simpler shorter
drug regimens for treatment. As of 2019, one year following the UN meeting no new technology
was released in 2019. There is still not a single rapid, accurate and robust TB diagnostic test. As
for drug treatment, there are 23 drugs in the works for drug-susceptible, MDR, and latent TB as
well as 14 vaccine candidates in trial. 168 While there is hope for future progress, the goals of the
global healt community are evidence of the priority placed on vaccines and treatment as the main
forces to stop TB rather than other factors such as undernourishment. However, putting more
effort and investment in structural issues may have more long-term impact on TB, as well as
other public health issues. growing disinterest of international donors is dwindling indicating that
eradicating TB.
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Conclusion
TB is still impacting millions of people each year around the world. The importance of
how the burden is presented and the information that is considered important for risk factors is
vital in its eradication. In the US, the CDC categorizes TB burden between “foreign-born” and
“US-born” people and states that the majority of cases are among “foreign-born” individuals,
who have also been in the US for at least a decade. The categorization of cases being either
“foreign-born” or “US-born” is highly problematic namely because it emphasizes the TB has
been imported from elsewhere rather than acknowledging that there are structural factors in play
in the US, such as food insecurity, as well as other that influence the development of active TB
in the US. The association of “foreign-born” people is perpetuating a xenophobic idea that
immigrants are the carriers of the disease. The lack of attention placed on combating structural
issues carries over into US global health efforts where aspects of TB control related to vaccine
and drug development is given priority over systemic issues.
The categorization of “ foreign-born” people as a factor of the burden of TB in the US
suggests that the data collection and subsequent policy proposals of the CDC are complicit in
racist and capitalist policies that further exploit minority groups such as immigrants, who also
are most burdened by TB in the US. The CDC does not challenge the structural issues associated
with potential risk of TB and so perpetuates these in just systems. The relationship between food
insecurity and TB needs to be researched further as it could be a major factor in the development
of TB in the US. The CDC is holding themselves back from eliminating TB in the U.S. with so
much focus on the fact that a patient is “foreign-born” rather than other factors that may have
influence the development of TB more. The presentation of data indicating that immigrants are
disproportionately impacted by TB can show inequality and structural issues in society but also
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can hinder effectiveness of interventions and efforts. Without an deep look at the structural
issues that impact TB disease development, the elimination of TB will be nearly impossible. In
Abel’s historical analysis of exclusionary policies regarding TB she concluded that “only when
we acknowledge our membership in a global community will we be able to extirpate
tuberculosis. Rather than erecting higher and higher barriers against “outsiders,” we must
improve living standards and distribute effective public health programs both at home and
abroad.”169 This is still holds true. The social determinants of TB are vital in understanding the
true TB burden and subsequent effective solutions for TB. If investments in structural issues are
made, then maybe TB can be eliminated for good.

169

Abel, TB and Politics of Exclusion, 140.
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